Seller comparison · US self-pay prices

LillyDirect (Eli Lilly) vs MEDVi: Which Is Cheaper? GLP-1 Prices Compared

Last updated

Each seller's lowest price now

The same medicine for less than LillyDirect (Eli Lilly) and MEDVi, at sellers we link to

  • Compounded semaglutide, not FDA-approved

    Eden

    $99/mo · about $107 less per 30 days than MEDVi

  • Compounded tirzepatide, not FDA-approved

    Eden

    $129/mo · about $182 less per 30 days than MEDVi

They pay us if you buy, which never changes a price we show.

LillyDirect (Eli Lilly) and MEDVi have no listed product in common here: LillyDirect (Eli Lilly) lists Foundayo pill (from $149/mo), Zepbound injection ($299-$449/28 days), Trulicity injection (from $389/28 days), and Mounjaro injection (from $499/28 days); MEDVi lists compounded semaglutide injection ($199/mo) and compounded tirzepatide injection ($299/mo). Both sell tirzepatide, as different products: Zepbound injection and Mounjaro injection at LillyDirect (Eli Lilly), compounded tirzepatide injection at MEDVi. What each lists a price for here: LillyDirect (Eli Lilly), FDA-approved brand-name GLP-1s only; MEDVi, compounded GLP-1s only. Compounded GLP-1s are not FDA-approved. Prices checked Nov 11, 2026 and Nov 13, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Different products

What LillyDirect (Eli Lilly) and MEDVi each list

Both sell tirzepatide, as different products: Zepbound injection and Mounjaro injection at LillyDirect (Eli Lilly), compounded tirzepatide injection at MEDVi.

LillyDirect (Eli Lilly)
  • Foundayo pill

    Advertised entry price

    from $149/mo (lilly.com/lillydirect/foundayo)

    30-day supply (lilly.com)

    $149 per 30 days at this quoted rate

    Checked on lilly.com

    Foundayo (LillyDirect self-pay)

    LillyDirect (Eli Lilly) · maker's own price

    self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month")

    Price conditions

    self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month")

    LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    30-day supply

    Published maintenance dose

    $299/mo (lilly.com/lillydirect/foundayo/foundayo-full-terms-conditions)

    30-day supply (lilly.com)

    $299 per 30 days at this quoted rate

    Checked on lilly.com

    At 17.2 mg

    Foundayo (LillyDirect self-pay)

    LillyDirect (Eli Lilly) · maker's own price

    Published price at 17.2 mg

    Price conditions

    Published price at 17.2 mg

    LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.

    30-day supply

  • Zepbound injection

    Advertised entry price

    $299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)

    28-day supply (zepbound.lilly.com)

    ≈ $320.36 per 30 days at this quoted rate

    Checked on zepbound.lilly.com

    Zepbound KwikPen (multi-dose pen)

    LillyDirect (Eli Lilly) · maker's own price

    self-pay cash, by dose ($299 / $399 / $449)

    Price conditions

    self-pay cash, by dose ($299 / $399 / $449)

    Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

    28-day supply

    Published maintenance dose

    $449/28 days (zepbound.lilly.com/hcp/coverage-savings)

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days at this quoted rate

    Checked on zepbound.lilly.com

    At 15 mg

    Zepbound KwikPen (multi-dose pen)

    LillyDirect (Eli Lilly) · maker's own price

    Published price at 15 mg

    Price conditions

    Published price at 15 mg

    Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

    Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    28-day supply

  • Trulicity injection

    Advertised entry price

    from $389/28 days (lilly.com/lillydirect/trulicity)

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days at this quoted rate

    Checked on lilly.com

    Trulicity single-dose pens

    LillyDirect (Eli Lilly) · maker's own price

    self-pay, four weekly pens; published starting rate at each dose

    Price conditions

    self-pay, four weekly pens; published starting rate at each dose

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    28-day supply

    Published maintenance dose

    from $389/28 days (lilly.com/lillydirect/trulicity)

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days at this quoted rate

    Checked on lilly.com

    At 4.5 mg

    Trulicity single-dose pens

    LillyDirect (Eli Lilly) · maker's own price

    Published price at 4.5 mg

    Price conditions

    Published price at 4.5 mg

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply.

    28-day supply

  • Mounjaro injection

    Advertised entry price

    from $499/28 days (lilly.com/lillydirect/mounjaro)

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days at this quoted rate

    Checked on lilly.com

    Mounjaro single-dose pens

    LillyDirect (Eli Lilly) · maker's own price

    self-pay, four weekly pens; published starting rate at each dose

    Price conditions

    self-pay, four weekly pens; published starting rate at each dose

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    28-day supply

    Published maintenance dose

    from $499/28 days (lilly.com/lillydirect/mounjaro)

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days at this quoted rate

    Checked on lilly.com

    At 15 mg

    Mounjaro single-dose pens

    LillyDirect (Eli Lilly) · maker's own price

    Published price at 15 mg

    Price conditions

    Published price at 15 mg

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.

    28-day supply

MEDVi
  • Compounded semaglutide injection

    Advertised entry price

    $199/mo (glp1.medvi.org)

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Checked on glp1.medvi.org

    Compounded semaglutide via MEDVi

    MEDVi · seller's own price

    refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Price conditions

    refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

  • Compounded tirzepatide injection

    Advertised entry price

    $299/mo (glp1.medvi.org/results/cv-tirz)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Checked on glp1.medvi.org

    Compounded tirzepatide via MEDVi

    MEDVi · seller's own price

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Price conditions

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    28-day supply

    Published maintenance dose

    $299/mo (glp1.medvi.org/results/cv-tirz)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Checked on glp1.medvi.org

    At 15 mg

    Compounded tirzepatide via MEDVi

    MEDVi · seller's own price

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Price conditions

    monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    The seller states one price at every dose, so this is also its price at 15 mg.

    28-day supply

Same medication, lower price

Cheaper than LillyDirect (Eli Lilly) and MEDVi

Other sellers' current prices for the same product, below the lower of these two, compared per 30 days where both state their supply. Compounded medication is compared only with compounded, and an FDA-approved product only with itself.

Compounded, not FDA-approved

Compounded semaglutide

Lower than MEDVi. MEDVi: $199/mo, checked Nov 11, 2026 on glp1.medvi.org.

  1. Collective: $59/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. Sunlight: $78/mo, about $84 per 30 days. Checked Nov 11, 2026 on sunlight.com.View offer
  3. Avono Health: $79/mo. Checked Nov 13, 2026 on avonohealth.com.View offer
  4. Embody: $79/mo. Checked Nov 14, 2026 on joinem.co.View offer

Compounded, not FDA-approved

Compounded tirzepatide

Lower than MEDVi. MEDVi: $299/mo, checked Nov 13, 2026 on glp1.medvi.org.

  1. Collective: $69/mo + $199/yr membership. Checked Nov 15, 2026 on collective.org.View offer
  2. FlatRx: $118/mo. Checked Nov 17, 2026 on flatrx.io.View offer
  3. Arbor: $119/mo. Checked Nov 13, 2026 on startarbor.com.View offer
  4. Mint Med: $119/mo. Checked Nov 11, 2026 on mintmed.com.View offer

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)

Questions

LillyDirect (Eli Lilly) vs MEDVi: common questions

Is LillyDirect (Eli Lilly) or MEDVi cheaper for GLP-1 medication?

They have no listed product in common here, so neither is shown as cheaper for the same medication. Only LillyDirect (Eli Lilly): Foundayo pill from $149/mo; Zepbound injection $299-$449/28 days; Trulicity injection from $389/28 days; Mounjaro injection from $499/28 days. Only MEDVi: Compounded semaglutide injection $199/mo; Compounded tirzepatide injection $299/mo. Both sell tirzepatide, as different products: Zepbound injection and Mounjaro injection at LillyDirect (Eli Lilly), compounded tirzepatide injection at MEDVi. A compounded product is not a cheaper version of an FDA-approved brand; it is a different, unapproved product.

Do LillyDirect (Eli Lilly) and MEDVi sell FDA-approved GLP-1s or compounded versions?

What each lists a price for here: LillyDirect (Eli Lilly), FDA-approved brand-name GLP-1s only; MEDVi, compounded GLP-1s only. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do LillyDirect (Eli Lilly) and MEDVi prices include?

LillyDirect (Eli Lilly), Foundayo pill: from $149/mo, self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month"). LillyDirect (Eli Lilly), Zepbound injection: $299-$449/28 days, self-pay cash, by dose ($299 / $399 / $449). LillyDirect (Eli Lilly), Trulicity injection: from $389/28 days, self-pay, four weekly pens; published starting rate at each dose. LillyDirect (Eli Lilly), Mounjaro injection: from $499/28 days, self-pay, four weekly pens; published starting rate at each dose. MEDVi, compounded semaglutide injection: $199/mo, refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract. MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months).

When were LillyDirect (Eli Lilly) and MEDVi prices last checked?

Prices checked Nov 11, 2026 and Nov 13, 2026. Each quote names the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

Every sourced offer

All LillyDirect (Eli Lilly) and MEDVi offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

9 current prices

Lowest starting 30-day cost ·

  • View
    from $149/mo (lilly.com/lillydirect/foundayo)

    Checked on lilly.com

    Top dose:$299/mo (lilly.com/lillydirect/foundayo/foundayo-full-terms-conditions)at 17.2 mg

    Checked on lilly.com

    Terms & source

    Advertised price: self-pay cash, lowest dose; as low as $25 a month for eligible patients with commercial coverage for Foundayo ("you could pay as low as $25 a month")

    30-day supply (lilly.com)

    $149 per 30 days at this quoted rate

    Top-dose terms: Self-Pay Journey price for 14.5 mg and 17.2 mg with a refill within 45 days; regular price $349. Eligibility, additional taxes and fees may apply.

    LillyDirect self-pay ladder, each a 30-day supply: $149 (0.8 mg), $199 (2.5 mg), $299 (5.5 and 9 mg), $299 (14.5 and 17.2 mg with a 45-day refill, else $349); the 2.5 mg and 5.5 mg doses are temporarily $149 and $199 through Dec 31, 2026.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (lilly.com)
  • View
    $199/mo (glp1.medvi.org)

    Checked on glp1.medvi.org

    Top dose: No separate price on record

    Terms & source

    Advertised price: refill price after a $99 first month advertised as a "FALL Sale" with no end date; physician review, personalized plan, guidance and the medication included; no contract

    Billed per month; days of supply not on record, so ordered as four weekly doses.

    Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • View
    $299-$449/28 days (zepbound.lilly.com/hcp/coverage-savings)

    ≈ $320.36 per 30 days

    Checked on zepbound.lilly.com

    Top dose:$449/28 days (zepbound.lilly.com/hcp/coverage-savings)at 15 mg

    ≈ $481.07 per 30 days

    Checked on zepbound.lilly.com

    Terms & source

    Advertised price: self-pay cash, by dose ($299 / $399 / $449)

    28-day supply (zepbound.lilly.com)

    ≈ $320.36 per 30 days at this quoted rate

    Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    Each pen holds four doses, one month's (28-day) supply. $299 at 2.5 mg and $399 at 5 mg; $449 at 7.5 to 15 mg under the Self Pay Journey offer, which holds only with a refill within 45 days.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (zepbound.lilly.com)
  • View
    $299/28 days (zepbound.lilly.com/hcp/coverage-savings)

    ≈ $320.36 per 30 days

    Checked on zepbound.lilly.com

    Top dose:$449/28 days (zepbound.lilly.com/hcp/coverage-savings)at 15 mg

    ≈ $481.07 per 30 days

    Checked on zepbound.lilly.com

    Terms & source

    Advertised price: self-pay cash, starting dose

    28-day supply (zepbound.lilly.com)

    ≈ $320.36 per 30 days at this quoted rate

    Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    Self-pay only, available exclusively through LillyDirect Pharmacy. Lilly states that 2.5 mg starts treatment and is not a maintenance dose.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (zepbound.lilly.com)
  • View
    $299/mo (glp1.medvi.org/results/cv-tirz)

    ≈ $320.36 per 30 days

    Checked on glp1.medvi.org

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription; "3-Month Plan" "12 Week Supply" "Select Plan • $193/mo"; "6-Month Plan" "24 Week Supply" "Select Plan • $183/mo"; "12-Month Plan" "48 Week Supply" "Select Plan • $166/mo" ($193/mo on 3 months, $183/mo on 6 months, $166/mo on 12 months)

    28-day supply (glp1.medvi.org)

    ≈ $320.36 per 30 days at this quoted rate

    Other plan lengths

    • $193/mo on 3 months
    • $183/mo on 6 months
    • $166/mo on 12 months

    Top-dose terms: The seller states one price at every dose, so this is also its price at 15 mg.

    Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

    Partner: This seller may pay us a referral fee if you buy through our link, at no extra cost to you. That moves it up in our default order, never in a lowest-cost sort, and is not a medical recommendation.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (glp1.medvi.org)
  • View
    from $389/28 days (lilly.com/lillydirect/trulicity)

    ≈ $416.79 per 30 days

    Checked on lilly.com

    Top dose: same price at 4.5 mg

    Terms & source

    Advertised price: self-pay, four weekly pens; published starting rate at each dose

    28-day supply (lilly.com)

    ≈ $416.79 per 30 days at this quoted rate

    Top-dose terms: The same starting rate is published for 0.75, 1.5, 3 and 4.5 mg. Taxes and additional fees may apply.

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (lilly.com)
  • View
    $399/28 days (zepbound.lilly.com/hcp/coverage-savings)

    ≈ $427.50 per 30 days

    Checked on zepbound.lilly.com

    Top dose:$449/28 days (zepbound.lilly.com/hcp/coverage-savings)at 15 mg

    ≈ $481.07 per 30 days

    Checked on zepbound.lilly.com

    Terms & source

    Advertised price: self-pay cash

    28-day supply (zepbound.lilly.com)

    ≈ $427.50 per 30 days at this quoted rate

    Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    Self-pay only, available exclusively through LillyDirect Pharmacy.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (zepbound.lilly.com)
  • View
    $449/28 days (zepbound.lilly.com/hcp/coverage-savings)

    ≈ $481.07 per 30 days

    Checked on zepbound.lilly.com

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: self-pay cash, higher doses

    28-day supply (zepbound.lilly.com)

    ≈ $481.07 per 30 days at this quoted rate

    Top-dose terms: Self Pay Journey price for 7.5-15 mg with a refill within 45 days; otherwise $499 (7.5 mg) or $699 (10-15 mg).

    The $449 rate is the Self Pay Journey Program price and holds only with a refill within 45 days; miss the window and the higher doses revert to the regular single-dose vial price of $499 (7.5 mg) or $699 (10 mg, 12.5 mg, and 15 mg).

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (zepbound.lilly.com)
  • View
    from $499/28 days (lilly.com/lillydirect/mounjaro)

    ≈ $534.64 per 30 days

    Checked on lilly.com

    Top dose: same price at 15 mg

    Terms & source

    Advertised price: self-pay, four weekly pens; published starting rate at each dose

    28-day supply (lilly.com)

    ≈ $534.64 per 30 days at this quoted rate

    Top-dose terms: The same starting rate is published for all six strengths, 2.5-15 mg. Taxes and additional fees may apply.

    The self-pay program requires a prescription for an approved use, age 18+, and US or Puerto Rico residence. Purchases cannot be submitted to insurance or counted toward deductibles or out-of-pocket limits. LillyDirect defines a month's supply as four single-dose pens, one a week, so a fill covers 28 days.

    Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the seller. A listed offer does not confirm eligibility or stock.

    Advertised price as read on its own page (lilly.com)

Read prices in context. Compare the same product, dose and payment terms; missing prices are not estimated. Compounded medicines are not FDA-approved.

How this list is ordered. Some sellers may pay us a referral fee, as their terms say. In this sort they are not moved up, and it never changes what you pay.

How prices are compared, what FDA says about compounding and how we earn

A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes, converted to 30 days: by the supply a price buys where the seller states it in days, otherwise a monthly price with its plan length on record read as four weekly doses, a yearly membership in the price spread over twelve months. Introductory prices, ranges, prices with no plan length on record and separately billed fees are unranked references. Dose changes and added fees affect what you pay.

A listed maintenance dose is not a dosing recommendation.

FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize). Its conditions for a pharmacy compounding them now include "The drug product is compounded for an individual patient based on receipt of a prescription" and "The compounder does not compound, regularly or in inordinate amounts, any that are essentially copies of a commercially available drug product." (fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) In May 2026 FDA proposed leaving semaglutide, tirzepatide and liraglutide off the 503B Bulks List (federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal), the ingredients outsourcing facilities may compound from; comments closed Jul 30, 2026 (govinfo.gov/content/pkg/FR-2026-06-26/html/2026-12937.htm), and we found no final notice when we last read the Federal Register (Nov 6, 2026). FDA's newest warning letter to a pharmacy over compounded semaglutide or tirzepatide went to Empower Clinic Services, LLC dba Empower Pharmacy (fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/empower-clinic-services-llc-dba-empower-pharmacy-738238-09182026) on Sep 18, 2026 (every GLP-1 warning letter). FDA's newest recall report of a compounded semaglutide or tirzepatide product is Houston Rx LLC's tirzepatide (api.fda.gov/drug/enforcement.json), reported Oct 21, 2026: "Lack of assurance of sterility." (every tirzepatide recall). Liraglutide is different: FDA's shortage database (accessdata.fda.gov/scripts/drugshortages) still lists it in shortage (updated at source Oct 14, 2026; every GLP-1 shortage). FDA: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." (fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers) A low price is not a low-risk signal; confirm current terms with the provider.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.

Public record

LillyDirect (Eli Lilly) vs MEDVi: reviews, BBB and FDA

What Trustpilot, the BBB and the FDA say about each. These records do not measure medical quality or results.

MEDVi

Trustpilot 4.3 from 15,227 reviews. The BBB rates MEDVi F, with 789 complaints filed in the last 3 years. It is not BBB accredited. The FDA sent MEDVi a warning letter (Feb 20, 2026) about claims on its website. The words that letter quotes ("Same active ingredient as Wegovy® and Ozempic®") were on none of the 3 pages of home.medvi.org and glp1.medvi.org we read on Nov 16, 2026.

Is MEDVi legit?

Seller pages re-read automatically : 2 of 6 opened and checked for price changes. How prices stay current

Updated automatically

LillyDirect (Eli Lilly) and MEDVi price changes

  • Seller recordMEDVi: updated record on its public ratings and records
  • PriceMEDVi: Compounded tirzepatide via MEDVi now ranked per 30 days at about $320: $299/mo buys 28 days (read on glp1.medvi.org)
  • Seller recordMEDVi: updated record on who makes its medicine (read on home.medvi.org)
  • PriceMEDVi: Compounded semaglutide via MEDVi now $199/mo (was $299/mo) (read on glp1.medvi.org)

Written from each source's own record as it changes. Every change on GLPcompare

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.